Product Information
CARVEDILOL 3.125 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.0170 per EA under NDC 68001015300. Its NADAC has been published 644 times since Feb 26, 2014.
Strength
3.125 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001015300
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARVEDILOLApproval Type
Generic (ANDA)
FDA Application
ANDA077614On Market Since
4/22/2014
Pharmacological Classes
Price Statistics
The NADAC for CARVEDILOL 3.125 MG TABLET has been published 644 times since Feb 26, 2014, and over the history we have for it it has declined 54.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0170 per EA |
|---|---|
| All-time high | $0.0370 (Mar 12, 2014) |
| All-time low | $0.0133 (Nov 20, 2024) |
| 52-week high | $0.0174 |
| 52-week low | $0.0163 |
| Median price | $0.0231 |
| Average price | $0.0237 |
| Largest weekly change | -22.2% (Nov 20, 2024) |
| Weeks tracked | 644 |
| Tracking since | Feb 26, 2014 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARVEDILOL 3.125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL 3.125 MG TABLET, manufactured by BluePoint Laboratories, is $0.0170 per EA (NDC 68001015300), effective Jun 24, 2026.
How has the price of CARVEDILOL 3.125 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARVEDILOL 3.125 MG TABLET has declined 54.0%. It has been tracked across 644 weekly CMS publications since Feb 26, 2014.
What are the highest and lowest recorded NADAC prices for CARVEDILOL 3.125 MG TABLET?
Since Feb 26, 2014, the NADAC for CARVEDILOL 3.125 MG TABLET has ranged from a low of $0.0133 (Nov 20, 2024) to a high of $0.0370 (Mar 12, 2014), with a median of $0.0231 per EA.
Are there cheaper alternatives to CARVEDILOL 3.125 MG TABLET?
9 NADAC-published products share the same active ingredient, strength, and dosage form as CARVEDILOL 3.125 MG TABLET, but none are currently priced below it.
Who manufactures CARVEDILOL 3.125 MG TABLET?
CARVEDILOL 3.125 MG TABLET (NDC 68001015300) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification